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ABSTRACT
Chaperone-mediated autophagy (CMA) is a selective degradative process for cytosolic proteins that
contributes to the maintenance of proteostasis. The signaling mechanisms that control CMA are not fully
understood but might involve response to stress conditions including oxidative stress. Considering the
role of CMA in redoxtasis and proteostasis, we sought to determine if the transcription factor NFE2L2/
NRF2 (nuclear factor, erythroid derived 2, like 2) has an impact on CMA modulation. In this work, we
identified and validated 2 NFE2L2 binding sequences in the LAMP2 gene and demonstrated in several
human and mouse cell types that NFE2L2 deficiency and overexpression was linked to reduced and
increased LAMP2A levels, respectively. Accordingly, lysosomal LAMP2A levels were drastically reduced in
nfe2l2-knockout hepatocytes, which also displayed a marked decrease in CMA activity. Oxidant chal-
lenge with paraquat or hydrogen peroxide, or pharmacological activation of NFE2L2 with sulforaphane
or dimethyl fumarate also increased LAMP2A levels and CMA activity. Overall, our study identifies for the
first time basal and inducible regulation of LAMP2A, and consequently CMA activity, by NFE2L2.
Abbreviations: ACTB: actin, beta, ARE: antioxidant response element; ATG5: autophagy related 5;
BACH1: BTB domain and CNC homolog 1; ChIP: chromatin immunoprecipitation; CMA: chaperone-
mediated autophagy; DHE: dihydroethidium; DMF: dimethyl fumarate; ENCODE: Encyclopedia of DNA
elements at the University of California, Santa Cruz; GAPDH: glyceraldehyde-3-phosphate dehydrogen-
ase; GBA: glucosylceramidase beta; GFP: green fluorescent protein; HMOX1: heme oxygenase 1; H2O2:
hydrogen peroxide; HSPA8/HSC70: heat shock protein family A (Hsp70) member 8; KEAP1: kelch like ECH
associated protein 1; LAMP2A: lysosomal associated membrane protein 2A; LAMP2B: lysosomal asso-
ciated membrane protein 2B; LAMP2C: lysosomal associated membrane protein 2C; LAMP1: lysosomal
associated membrane protein 1; MAFF: MAF bZIP transcription factor F; MAFK: MAF bZIP transcription
factor K; NFE2L2/NRF2: nuclear factor, erythroid derived 2, like 2; NQO1: NAD(P)H quinone dehydrogen-
ase 1; PQ: paraquat; PI: protease inhibitors; qRT-PCR: quantitative real-time polymerase chain reaction;
RNASE: ribonuclease A family member; SFN: sulforaphane; SQSTM1/p62: sequestosome 1; TBP: TATA-box
binding protein
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Introduction
Intracellular oxidized proteins can be eliminated by a selective
type of autophagy termed chaperone-mediated autophagy
(CMA). The main characteristic of this mode of autophagy
is the presence of a lysosomal receptor called LAMP2A (lyso-
somal associated membrane protein 2A). Soluble cytosolic
proteins bearing a KFERQ-like motif are recognized by
HSPA8/HSC70 (heat shock protein family A [Hsp70] member
8) [1–3]. HSPA8 delivers cargoes to the lysosome surface,
where they interact with LAMP2A [4]. Then, LAMP2A multi-
merizes in the lysosomal membrane to form a translocation
complex [5], so that unfolded substrates can enter the lyso-
some, assisted by lumenal HSPA8, and eventually be degraded
by lysosomal proteases [6,7]. The limiting step in the whole
process appears to be the availability of LAMP2A receptor at
the lysosomal membrane, as lysosomal LAMP2A levels have
been reported to correlate with CMA activity, and knockdown
or overexpression of LAMP2A results in a decrease or
increase in CMA proportional to the levels of expression
[4,8]. LAMP2A is one of the 3 proteins that originate from
alternative splicing of the LAMP2 gene. All LAMP2A,
LAMP2B and LAMP2C isoforms share an identical lumenal
region but differ in their cytosolic and transmembrane tail [9].
These isoforms result from cell-specific yet unknown regula-
tion of differential splicing [10,11] but experimental evidence
supports the conclusion that LAMP2A is the only LAMP2
variant required for CMA [4,8].
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Although basal CMA activity can be detected in most cell
types [12], this process is maximally activated in response to
stress. Activation of CMA is associated with increased levels of
LAMP2A and its multimerization to form membrane transloca-
tion complexes, lysosomal enrichment in HSPA8 and relocation
of lysosomes to the perinuclear region [13–15]. It has been
reported that a mild oxidant environment activates the expres-
sion of Lamp2a [14] and that this process is under the transcrip-
tional regulation of NFAT in T cells [16]. However, a generic
mechanism that might regulate the expression of LAMP2A
under these circumstances remains unknown.
NFE2L2/NRF2 (nuclear factor, erythroid derived 2, like 2),
participates in the control of metabolic redox processes
including degradation of oxidized proteins. NFE2L2 controls
the basal and stress-inducible expression of over 250 genes
that share a common a cis-acting enhancer termed the anti-
oxidant response element (ARE) [17]. These genes participate
in several cytoprotective functions such as phase I, II and III
detoxification reactions, glutathione and PRDX/peroxire-
doxin-TXN/thioredoxin metabolism, NADPH production
through the pentose phosphate pathway and ME (malic
enzyme), fatty acid oxidation or iron metabolism [18]. Most
of these reactions provide an armamentarium to control
redox homeostasis. Importantly for this study, we and others
previously reported that NFE2L2 can modulate the expression
of several genes involved in macroautophagy [19–22]. Thus,
we identified many NFE2L2-regulated genes involved in the
different phases of the macroautophagy process, from cargo
recognition to autolysosome clearance [22]. Considering this
evidence and the role of CMA in the cellular response to
oxidative stress [14], it might be feasible that NFE2L2 also
participates in the regulation of CMA, but this possibility has
not yet been investigated.
In this study, we show for the first time that NFE2L2 is
required for CMA activation through the transcriptional control
of LAMP2A expression, revealing a molecular pathway that
connects oxidative stress with CMA induction. Bearing in
mind that oxidized proteins accumulate in aging and in several
age-related pathological conditions [23], when CMA activity has
been shown to decline [24,25], this study provides a new strategy
to activate CMA through NFE2L2 inducers to facilitate elimina-
tion of such damaged and otherwise toxic proteins.
Results
NFE2L2 binds to functional antioxidant response
elements (ares) in the LAMP2 gene
We searched the Encyclopedia of DNA Elements at UCSC
(ENCODE) [26] of the human genome for putative AREs in
this gene (Figure 1a). The ENCODE database gathers experi-
mental data from chromatin immunoprecipitation (ChIP)
Figure 1. NFE2L2 binds to 2 functional antioxidant response elements (AREs) in the LAMP2 gene. (a) Scheme of the LAMP2 gene showing the 3 splice variants:
LAMP2A, LAMP2B and LAMP2C, from The Encyclopedia of DNA Elements at UCSC (ENCODE) for human genome. Putative AREs in the LAMP2 gene were identified
taking as reference the available information from ChIP of ARE-binding factors MAFK, MAFF and BACH1. These regions were localized in 200–400 base-pair-long
DNAse-sensitive and H3K27Ac-rich regions, i.e. most likely regulatory promoter regions. (b) HEK293T cells were transfected with an expression vector for
NFE2L2ΔETGE-V5 (lacking the KEAP1 regulatory domain). ChIP analysis was performed with anti-IgG or anti-V5 antibodies and the potential AREs with the highest
score, termed ARE1, ARE2 and ARE3 (Table 1), were analyzed by qRT-PCR. The figure shows representative data normalized as the fold of enrichment with the anti-V5
antibody vs. the IgG antibody. The presence of already known AREs in HMOX1, NQO1 and SQSTM1 was analyzed as positive control and ACTB, and a region of NQO1
that does not contain an ARE (NQO1*) were amplified as negative controls. (c), Luciferase reporter constructs carrying 3 tandem putative ARE sequences from the
LAMP2 gene (i-iii) or a scramble sequence as negative control (iv) controlling the expression of luciferase. (d) nfe2l2-KO mouse embryo fibroblasts were co-transfected
with the reporters in C and increasing amounts of NFE2L2ΔETGE-V5 construct. Values were normalized to pTK-Renilla activity and presented as fold of change. Data are
mean ± SD (n = 3). Statistical analysis was performed using Student’s t test. *p < 0.05, ** p < 0.01 and *** p < 0.001 vs. basal levels.
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analysis of ARE binding transcription factors MAFF, MAFK
and BACH1 although NFE2L2 is not analyzed. As shown in
Figure 1a, some of these binding sites were located at histone
acetylated and DNAse-sensitive regions in the LAMP2 gene,
both factors being typical of active enhancers. We then used a
Python-based bioinformatics analysis to scan these binding
regions for the consensus ARE as established in the JASPAR
database [27]. We detected 8 putative AREs in the LAMP2
gene (Table S1) and 3 of them showed a relative score higher
than 85%, a commonly used threshold for transcription factor
binding-site analysis [28,29]. Moreover, the analysis also
retrieved already identified AREs in the bona fide target
genes of NFE2L2, HMOX1 and SQSTM1/p62 (Table 1).
To validate the AREs with the highest score (termed ARE1,
ARE2 and ARE3), we next performed ChIP analysis with
NFE2L2. HEK293T cells were transfected with an expression
vector for V5-tagged NFE2L2ΔETGE. This construct lacks the
KEAP1 regulatory domain (ETGE) in order to facilitate
NFE2L2 stabilization, translocation to the nucleus and bind-
ing to target genes. NFE2L2 was immunoprecipitated with an
anti-V5 antibody and anti-IgG as a negative control. NFE2L2
binding was analyzed by qRT-PCR employing as template the
immunoprecipitated DNA and primers designed to specifi-
cally amplify ARE1, ARE2 or ARE3 (Table S2). NFE2L2
bound to well-known positive control AREs in HMOX1,
NQO1 and SQSTM1/p62, whereas NFE2L2 did not bind to
ACTB or to a region of NQO1 that does not contain any ARE
(NQO1*). Interestingly, NFE2L2 bound to ARE1 and ARE2 in
LAMP2 but not to ARE3 (Figure 1b and Table S3).
We next analyzed the functionality of these putative AREs.
Three tandem nucleotide sequences of each ARE or a control
scramble sequence were cloned in the promoter region of a
luciferase reporter as shown in Figure 1c. Nfe2l2-deficient
cells were transiently co-transfected with these constructs
and increasing amounts of NFE2L2-ΔETGE-V5. We found
that NFE2L2 expression induced luciferase expression in
reporters carrying ARE1 and ARE2 but not ARE3 or the
scramble negative control (Figure 1d). As an additional con-
trol, change of a highly conserved G to A in the putative
ARE1 and ARE2 sequences greatly reduced luciferase expres-
sion (Figure S1). Altogether, these results indicate that
NFE2L2 binds and activates, at least, 2 AREs in the LAMP2
gene, termed here ARE1 and ARE2.
LAMP2A levels are regulated by NFE2L2
To determine if, in fact, NFE2L2 has an impact on LAMP2A
expression, HEK293T cells were infected with a lentiviral
vector expressing GFP as negative control or NFE2L2 ΔETGE-
V5. As shown in Figure 2a-2c, NFE2L2 overexpression led to
a modest but consistent increase in LAMP2A levels as well as
in the positive controls HMOX1 and SQSTM1. In addition, we
used a knockdown strategy to reduce NFE2L2 activity in the
lung carcinoma cell line A549, which lacks KEAP1 and there-
fore exhibits high NFE2L2 protein levels. NFE2L2 knockdown
reduced mRNA and protein levels of HMOX1, SQSTM1 and
also LAMP2A (Figure 2d-2f).
Because CMA and NFE2L2 activity have been separately
well characterized in liver, we focused on the regulation of
LAMP2A by NFE2L2 in mouse hepatocytes. Messenger RNA
and protein levels of HMOX1, SQSTM1 and LAMP2A were
lower in nfe2l2-knockout (nfe2l2-KO) than in Nfe2l2-wild
type (Nfe2l2-WT) cells (Figure 3a, 3c and 3d). Moreover,
lentivirus-induced overexpression of NFE2L2ΔETGE-V5 par-
tially rescued the mRNA expression of these 3 genes in
nfe2l2-KO hepatocytes (Figure 3b). Lamp2b and Lamp2c iso-
forms were not significantly changed upon overexpression or
knockdown of NFE2L2 (Fig. S2), in agreement with the
reported regulation- and cell-specific expression of these 2
isoforms, which do not participate in CMA. Moreover, reduc-
tion of LAMP2A/Lamp2a levels in the absence of NFE2L2 was
also confirmed in human astrocytes, mouse hippocampal
cells, embryo fibroblasts and cortical neurons from Nfe2l2-
WT vs nfe2l2-KO mice (Fig. S3).
A modest reduction in LAMP2A levels was detected in
whole cell lysates of nfe2l2-KO when compared to Nfe2l2-
WT lysates (Figures 3c and 3d), and this reduction was
more evident when we compared isolated lysosomes
(Figures 3e and 3f), taking LAMP1 as a control lysosomal
protein that is not involved in CMA. We also analyzed
LAMP2A levels in lysosomes by immunofluorescence and,
as shown in Figures 3g and 3h, the overall intensity and the
number of puncta per cell of LAMP2A (red), which coloca-
lized with LAMP1 (green), were dramatically reduced in
nfe2l2-KO hepatocytes compared with Nfe2l2-WT hepato-
cytes. Altogether, NFE2L2 absence results in parallel changes
in mRNA and protein levels of LAMP2A, especially in the
lysosomal fraction.
NFE2L2 controls CMA under oxidant conditions
We characterized the redox status of immortalized hepatocytes
derived from Nfe2l2-WT or nfe2l2-KO mice. As shown in
Figures 4a and 4b, dihydroethidium (DHE) staining did not
reflect major differences in ROS levels between these cell types
under basal conditions. However, upon treatment for 16 h with
the oxidative stress-inducing drug paraquat (PQ), nfe2l2-KO
hepatocytes exhibited increased DHE fluorescence compared
to Nfe2l2-WT cells. As NFE2L2 controls the production of the
universal reducing agent NADPH, we analyzed the ratio
between oxidized NADP and reduced NADPH in these cells.
nfe2l2-KO hepatocytes showed an augmented NADP+:NADPH
ratio, which may be sufficient to handle ROS under basal
Table 1. Putative antioxidant response elements (AREs) with a relative score higher than the 85% in the LAMP2 gene.
ARE Localization of the potential ARE Max Score Relative score Putative binding sequence Region of the gene
ARE1 chrX:119,596,430–119,596,441 15.83 0.921 ATGACACTGCA Intron 1
ARE2 chrX:119 619,599–119,619,610 13.24 0.859 TTGACTCAGCG 5ʹ UTR (−16,500)
ARE3 chrX:119,619,560–119,619,571 13.07 0.855 ATGACAAACCA 5ʹ UTR (−16,500)
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conditions but not in the presence of oxidants such as PQ
(Figure 4c). Importantly, despite having higher ROS levels,
nfe2l2-KO hepatocytes failed to increase LAMP2A levels upon
PQ exposure (Figures 4d and 4e). Similar results were also
observed with hydrogen peroxide (Fig. S4A and S4B).
The modulation of CMA activity by NFE2L2 was further
analyzed in Nfe2l2-WT vs. nfe2l2-KO hepatocytes transduced
with a lentivirus expressing the photoactivable CMA-specific
fluorescent substrate KFERQ-PS-Dendra (modified from
Koga et al. [30]). Upon 405 nm light exposure, Dendra pro-
tein is modified to emit red fluorescence, making it possible to
track its delivery to lysosomes over newly synthesized protein.
CMA activity is detected as a change from diffuse (cytosolic)
fluorescence to a punctate (lysosomal) pattern, because CMA-
active lysosomes are highlighted as red fluorescent puncta
when the fluorescence substrate is delivered to this compart-
ment. As shown in Figures 4f and 4h, Nfe2l2-WT cells exhib-
ited a low cytosolic signal and some Dendra-positive
fluorescent puncta, reflecting basal CMA activity. However,
a more intense and diffuse fluorescent pattern throughout the
cytoplasm, together with an extremely reduced number of
Dendra-positive puncta per cell, were observed in nfe2l2-KO
cells, consistent with impaired basal CMA activity (the
KFERQ-PS-Dendra reporter is not being properly degraded
by CMA and accumulates in the cytosol). When cells were
treated for 16 h with PQ, a well-characterized stimulus for
CMA [14], we found a significant increase in Dendra-positive
puncta per cell in Nfe2l2-WT but not nfe2l2-KO hepatocytes,
indicating impaired induction of CMA by PQ in the absence
of NFE2L2 (Figures 4g and 4h).
Pharmacological activation of NFE2L2 induces LAMP2A
expression and CMA
We next used a well-established activator of NFE2L2, sul-
foraphane (SFN), to test if pharmacological activation of
NFE2L2 could lead to upregulation of LAMP2A levels and
CMA activity. Treatment of Nfe2l2-WT hepatocytes with
increasing doses of SFN for 16 h led to increased protein
levels of NFE2L2, HMOX1, SQSTM1 and also LAMP2A,
and this response was abolished in nfe2l2-KO cells
(Figures 5a and 5b). Similar results were obtained with the
NFE2L2 activator dimethyl fumarate (Fig. S4C and S4D).
We further extended these observations to other cell types
such as mouse embryonic fibroblasts, N2A neuroblastoma
cells, mouse hippocampus-derived HT22 and human kidney
Figure 2. LAMP2A levels are modified upon genetic manipulation of NFE2L2. (a) HEK293T cells were transduced with GFP- or NFE2L2ΔETGE-V5-expressing lentivirus
(LV-GFP or LV-NFE2L2, respectively). Expression levels of Hmox1, Sqstm1, Lamp2a, Lamp2b and Lamp2c were determined 3 days post-infection by qRT-PCR and
normalized by Actb levels. Lamp2c levels were barely detectable in this cell type (data not shown). Data are mean ± SD (n = 4). Statistical analysis was performed
with Student’s t test. ***p < 0.001 vs. LV-GFP-infected cells. (b) Representative immunoblots for the indicated proteins in cell lysates from cells transduced as in A.
The bracket indicates the band corresponding to LAMP2A. (c) Densitometric quantification of representative immunoblots from B relative to ACTB protein levels. Data
are mean ± SD (n = 4). Statistical analysis was performed using Student’s t test. *p < 0.05 vs. LV-GFP-infected cells. (d) A549 cells were transduced with lentivirus
carrying shRNA against a scramble sequence (shCTRL) or against NFE2L2 (shNFE2L2). Expression levels of Hmox1, Sqstm1, Lamp2a, Lamp2b and Lamp2c were
determined 3 days post-infection by qRT-PCR and normalized to Actb levels. Data are mean ± SD (n = 4). Statistical analysis was performed with Student’s t test.
*p < 0.05, **p < 0.01 and ***p < 0.001 vs. shCTRL infected cells. (e) Representative immunoblots for the indicated proteins in cell lysates from cells transduced as in
D. (f) Densitometric quantification of representative immunoblots from E relative to ACTB protein levels. Data are mean ± SD (n = 4). Statistical analysis was
performed using Student’s t test. **p < 0.01 and ***p < 0.001 vs. shCTRL infected cells.
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HEK293T cells, hence corroborating again the conservation
of this NFE2L2-LAMP2A axis among different cell types
(Fig. S5A and S5B). Moreover, SFN-treated cells displayed
mobilization of lysosomes (labeled either with LAMP2A or
LAMP1) toward the perinuclear region, a typical character-
istic of CMA activation [6]. Perinuclear LAMP2A fluores-
cence was much lower in nfe2l2-KO hepatocytes (Figures 5c
and 5d).
Furthermore, to directly confirm CMA activation, we
transduced cells with the KFERQ-PS-Dendra reporter.
Compared to untreated cells, SFN induced a significant
dose-dependent increase in Dendra-positive puncta per cell
in Nfe2l2-WT cells (note that because perinuclear relocation
made individual puncta indiscernible, data are presented as
punctate KFERQ-Dendra positive area per cell) (Figures 5e
and 5f). By contrast, SFN treatment failed to upregulate CMA
in the absence of NFE2L2. Previous studies have shown
compensatory cross-talk between CMA and macroautophagy.
Because we have shown before that NFE2L2 also exerts a
modulatory effect on macroautophagy, we next set out to
investigate if CMA activation upon SFN treatment was pri-
mary or reactive to changes in macroautophagy. In macro-
autophagy-deficient atg5-KO cells (Fig. S5C-F) we found that
SFN was still able to induce the expression of LAMP2A and
subsequent increase in CMA activity. These findings indicate
that the regulation of CMA by NFE2L2 is, for the most part,
independent of changes in macroautophagy activity.
Impaired CMA in lysosomes from livers of nfe2l2-KO mice
To analyze the functional role of NFE2L2 in the modulation
of CMA in vivo, we used livers of Nfe2l2-WT and nfe2l2-KO
mice. Consistent with our in vitro results with cultured hepa-
tocytes, mRNA levels of Hmox1, Sqstm1 and Lamp2a were
reduced in livers from nfe2l2-KO mice (Figure 6a). Analysis of
Figure 3. LAMP2A levels are reduced in the absence of NFE2L2. (a) Expression levels of Hmox1, Sqstm1 and Lamp2a from Nfe2l2-WT and nfe2l2-KO immortalized
hepatocytes were determined by qRT-PCR and normalized to Actb levels. Data are mean ± SD (n = 4). Statistical analysis was performed with Student’s t test.
**p < 0.01 and ***p < 0.001 vs. Nfe2l2-WT cells. (b) nfe2l2-KO immortalized hepatocytes were rescued with an NFE2L2ΔETGE-V5-expressing lentivirus (LV-NFE2L2).
Expression levels of Hmox1, Sqstm1 and Lamp2a was analyzed 3 days post-infection by qRT-PCR and normalized to Tbp levels. The dotted line represents expression
levels of nfe2l2-KO hepatocytes transduced with a control lentivirus (LV-GFP). Data are mean ± SD (n = 4). Statistical analysis was performed with Student’s t test.
**p < 0.01 and ***p < 0.001 vs. LV-CTRL infected cells. (c) Representative immunoblots for the indicated proteins in cell lysates from Nfe2l2-WT and nfe2l2-KO
immortalized hepatocytes. (d) Densitometric quantification of representative immunoblots from C relative to LMNB (lamin B) protein levels. Data are mean ± SD
(n = 3). Statistical analysis was performed using Student’s t test. **p < 0.01 and ***p < 0.001 vs. Nfe2l2-WT cells. (e) Representative immunoblots of LAMP2A and
LAMP1 in homogenates (Hom) and isolated lysosomes (Lys) from Nfe2l2-WT and nfe2l2-KO immortalized hepatocytes. (f) Densitometric quantification of
representative immunoblots from E relative to LAMP1 levels. Data are mean ± SD (n = 6). Statistical analysis was performed using Student’s t test. ***p < 0.001
vs. Nfe2l2-WT levels. (g) Confocal analysis of double immunofluorescence with anti-LAMP2A (red) and anti-LAMP1 (green) antibodies in immortalized Nfe2l2-WT and
nfe2l2-KO hepatocytes. The insert shows a higher magnification of the indicated cell. (h) Quantification of the total number of LAMP2A-positive puncta per cell.
Values are mean ± SD (n = 3, with > 50 cells counted per experiment). Statistical analysis was performed using Student’s t test. *p < 0.05 vs. Nfe2l2-WT cells.
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lysosomes isolated from these livers revealed a discrete
decrease in LAMP2A levels in the nfe2l2-KO group (Figures
6b and 6c). The discrete differences in lysosomal LAMP2A
levels are likely due to an overall increase in the ratio between
lysosomal components and cargo in the nfe2l2-KO mice
because of their lower CMA activity. In fact, contrary to the
decrease in LAMP2A, levels of other lysosomal resident pro-
teins such as HSPA8 and GBA were relatively higher in the
lysosomes of nfe2l2-KO mice (Figures 6b and 6c).
To directly measure CMA activity in the isolated lyso-
somes, we incubated them with purified recombinant
RNASE/RNAse A, a bona fide substrate of CMA [31], in
the absence or presence of protease inhibitors (PI). The
amount of RNASE recovered in untreated lysosomes
represents the fraction bound at the lysosomal membrane,
because the protein internalized during the incubation is
rapidly degraded. Pretreatment with PI allows recovering
lysosomes with both the RNASE bound and internalized.
Thus, uptake was calculated as the difference in RNASE
levels between non-treated and PI-treated conditions. As
shown in Figures 6d and 6e, lysosomes from nfe2l2-KO
mice showed a trend toward reduced RNASE uptake in
comparison with Nfe2l2-WT littermates, although it did
not reach statistical significance. We confirmed that the
observed differences were not due to loss of lysosomal
membrane integrity (Fig. S6A) or reduced proteolytic
activity, which was in fact higher in the absence of
NFE2L2 (Fig. S6B).
Figure 4. The oxidant agent paraquat (PQ) induces LAMP2A expression and CMA activity in an NFE2L2-dependent manner. (a) Representative images of ROS levels
determined with the dihydroethidium probe (DHE) in immortalized Nfe2l2-WT and nfe2l2-KO hepatocytes in basal conditions or after treatment with 200 µM PQ for
16 h. The probe was added to a final concentration of 5 µM in the culture medium 1 h before in vivo imaging of the cells. (b) Corrected total cell fluorescence of
representative images from A. Values are mean ± SD (n = 100 cells, derived from at least 3 different fields). Statistical analysis was performed using Student t test.
***p < 0.001 vs. untreated conditions. (c) NADP:NADPH ratio in immortalized Nfe2l2-WT and nfe2l2-KO hepatocytes. Data are mean ± SD (n = 4). Statistical analysis
was performed using Student’s t test. **p < 0.01 vs. Nfe2l2-WT cells. (d) Immortalized hepatocytes from Nfe2l2-WT and nfe2l2-KO mice were submitted to the
indicated concentrations of PQ for 16 h. Representative immunoblots for the indicated proteins in cell lysates. Note that anti-NFE2L2 antibody recognizes a
nonspecific band in nfe2l2-KO cells. (e) Densitometric quantification of representative immunoblots from D relative to LMNB protein levels. Data are mean ± SD
(n = 3). Statistical analysis was performed using Student’s t test. *p < 0.05, **p < 0.01 and ***p < 0.001 vs. untreated conditions. (f and g) Nfe2l2-WT and nfe2l2-KO
hepatocytes were transduced with lentivirus carrying the CMA reporter KFERQ-PS-Dendra and, after photoswitching, were cultured without additions (f) or in the
presence of 100 µM paraquat (PQ) (g) for 16 h. CMA was analyzed as the number of fluorescent puncta per cell at the end of the incubation time. Representative full-
field images and insert showing black and white high magnification of the boxed regions in the Dendra channel. (h) Quantification of the number of puncta per cell
after the indicated treatment. Values are mean ± SD (n = 3, with > 75 cells per experiment). Statistical analysis was performed using Student’s t test. **p < 0.01 and
***p < 0.001 vs. Nfe2l2-WT cells or untreated conditions.
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To gain further insight into the role of NFE2L2 in the
modulation of CMA in vivo we directly measured the
degradation of the endogenous CMA substrate GAPDH
in lysosomes from Nfe2l2-WT and nfe2l2-KO mice. Mice
were starved for 24 h to maximally induce CMA, and then
injected intraperitoneally with vehicle or leupeptin to
block proteolysis inside lysosomes. Because LAMP2A and
LAMP1 levels may oscillate with leupeptin due to changes
in the ratio between cargo and lysosomal components, in
this case we normalized lysosomal GAPDH with total
lysosomal protein as stained with Ponceau Red. As
shown in Figures 6f and 6g, GAPDH accumulated in
lysosomes from leupeptin-treated Nfe2l2-WT mice but
not nfe2l2-KO mice, although these animals exhibited
higher basal levels of lysosomal GAPDH. These results
suggest that NFE2L2 deficiency impairs basal CMA at
the level of substrate internalization.
Discussion
In this study, we report a molecular link between the tran-
scription factor NFE2L2 and CMA, which occurs through the
Figure 5. Pharmacological activation of NFE2L2 induces LAMP2A levels and CMA activation. (a) Immortalized hepatocytes from Nfe2l2-WT and nfe2l2-KO mice were
submitted to the indicated concentrations of sulforaphane (SFN) for 16 h. Representative immunoblots for the indicated proteins in cell lysates. Note that anti-NFE2L2
antibody recognizes a nonspecific band in nfe2l2-KO cells. (b) Densitometric quantification of representative immunoblots from A relative to LMNB protein levels.
Data are mean ± SD (n = 3). Statistical analysis was performed using Student’s t test. *p < 0.05, **p < 0.01 and ***p < 0.001 vs. untreated conditions. (c) Confocal
analysis of double immunofluorescence with anti-LAMP2A (red) and anti-LAMP1 (green) antibodies in immortalized Nfe2l2-WT and nfe2l2-KO hepatocytes treated
with vehicle (VEH) or 15 µM SFN for 16 h. The insert shows a higher magnification of the indicated cells. (d) Radial profile of LAMP2A fluorescence in cells treated
with SFN in A. The graph shows the total mean fluorescence as a function of radial distance to the center of the cell. The dashed line represents the nuclear limits.
Values are mean ± SD (n = 3, with > 50 cells counted per experiment). (e) Nfe2l2-WT and nfe2l2-KO hepatocytes were transduced with lentivirus carrying the CMA
reporter KFERQ-PS-Dendra and, after photoswitching, were cultured without additions or in the presence of 10 µM or 20 µM SFN for 16 h. CMA was analyzed as the
number of fluorescent puncta per cell at the end of the incubation time. Representative full-field images and insert showing black and white high magnification of
the boxed regions in the Dendra channel. (f) Quantification of the KFERQ-Dendra-positive area per cell. Values are mean ± SD (n = 3, with > 75 cells per experiment).
Statistical analysis was performed using Student t test. **p < 0.01 and ***p < 0.001 vs. untreated conditions.
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control of LAMP2A transcription. Knockout of Lamp2a or
Nfe2l2 makes cells more susceptible to different stressors
[8,32], indicating a crucial role in the maintenance of cell
homeostasis under different circumstances. In fact, previous
work supports the notion that redox status tightly controls
CMA activity, presumably to eliminate proteins oxidized dur-
ing mild oxidative damage [14]. Interestingly, CMA induction
upon oxidative stress appears to occur through increased
Lamp2a transcription [14], whereas CMA activation by nutri-
ent deprivation relies on diminished degradation of LAMP2A
and relocation of this receptor at the lysosomal membrane
[33], pointing to the existence of several mechanisms of CMA
regulation.
Several transcription factors might regulate LAMP2
expression. AP-1 and SP1 binding sites were found in the
LAMP2 promoter [34], although they were not confirmed to
be functional enhancers. MAF proteins, the other bZIP part-
ner of the NFE2L2 heterodimer, heterodimerize also with
NFAT (nuclear factor of activated T cells), which upon acti-
vation modulates Lamp2a transcription in T lymphocytes
[16]. We have identified 2 functional AREs in the LAMP2
gene that lose activity when a highly conserved G is replaced
to A. This is the binding site for MAF [35] and consequently
we suggest that MAFs participate in a dual regulation of
LAMP2 by both NFAT and NFE2L2. Of note, NFE2L2
would control not only inducible but also Lamp2a basal
expression, as Nfe2l2-deficient cells exhibited reduced
Lamp2a mRNA and protein levels. It is thus possible that
different transcription factors co-exist to assure proteostasis
under several circumstances and in distinct cell types. In fact,
levels of basal CMA activity and the amplitude of the induc-
tion varies among different cell types [12,16,36,37].
Importantly, this novel NFE2L2-LAMP2A axis is conserved
in different cell types.
Despite being encoded by the same gene, different trans-
membrane and cytosolic regions in each LAMP2 spliced var-
iant enable specific functions. In fact, several roles have been
proposed for LAMP2B and LAMP2C [10,38–40], but
LAMP2A is the only isoform required for CMA [4,8,25].
LAMP2 isoforms display tissue-specific expression patterns
[10,41]. While LAMP2A and LAMP2B are highly expressed
in most tissues, LAMP2C appears to be very restricted [10],
pointing to a different splicing regulation of the LAMP2 gene.
Although we could not detect differences in the expression
levels of LAMP2B or LAMP2C upon genetic manipulation of
NFE2L2 in human HEK293T cells, mouse hepatocytes or
HT22 cells, reduced levels of LAMP2B mRNA were found in
A549 cells upon NFE2L2 silencing, and NFE2L2-deficient
MEFs displayed reduced levels of the 3 isoforms. Differential
regulation of the 3 isoforms has been reported previously
[10,15,42]. For example, paraquat transcriptionally induces
Lamp2a expression without affecting the other 2 isoforms
Figure 6. Role of NFE2L2 in the modulation of CMA in vivo. (a) Expression levels of Hmox1, Sqstm1 and Lamp2a in livers from Nfe2l2-WT and nfe2l2-KO mice were
determined by qRT-PCR and normalized by the geometric mean between Actb and Tbp levels. Data are mean ± SEM (n = 4). Statistical analysis was performed using
Student’s t test. **p < 0.01 and ***p < 0.001 vs. Nfe2l2-WT mice. (b) Immunoblots for the indicated proteins in homogenates and isolated lysosomes from livers of
Nfe2l2-WT or nfe2l2-KO mice. Note that anti-NFE2L2 antibody recognizes a nonspecific band in nfe2l2-KO cells. (c) Densitometric quantification of lysosomal proteins
in B relative to LAMP1 levels. Data are mean ± SD (n = 3 livers per mouse genotype). Statistical analysis was performed using Student’s t test. *p < 0.05 vs. Nfe2l2-WT
mice. (d) Lysosomes isolated from livers of Nfe2l2-WT or nfe2l2-KO mice were pretreated or not with protease inhibitors (PI) to inhibit lysosomal proteolysis and
incubated with purified RNASE for 20 min at 37ºC. At the end of the incubation, lysosomes were recovered by centrifugation and subjected to SDS-PAGE and
immunoblot for the indicated proteins. LAMP1 is shown as control of similar lysosomal recovery after the incubation. (e) Densitometric quantification of RNASE
binding (Bin) and uptake (Upt) in Nfe2l2-WT or nfe2l2-KO isolated lysosomes. Data are mean ± SD (n = 3 livers per mouse genotype). Statistical analysis was
performed using Student’s t test. (f) Nfe2l2-WT and nfe2l2-KO mice were starved for 24 h. Lysosomal proteolysis was inhibited in vivo with 2 intraperitoneal injections
of leupeptin (2 mg/100g body weight) 16 and 2 h before sacrifice. Representative immunoblots of the indicated endogenous proteins in lysosomal-enriched fractions
from livers of Nfe2l2-WT (WT) and nfe2l2-KO (KO) mice. (g) Densitometric quantification of representative immunoblots from F relative to total protein levels stained
with Ponceau Red. Data are mean ± SD (n = 3). Statistical analysis was performed using Student’s t test. *p < 0.05 vs. Nfe2l2-WT vehicle-treated mice.
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[43]. Altogether, these data suggest the existence of additional
post-transcriptional regulatory mechanisms of the Lamp2
gene that need to be unveiled in future studies.
Chemical and genetic manipulation of NFE2L2 results in
modest changes in cellular LAMP2A mRNA and protein
levels, albeit similar to those observed for the NFE2L2-respon-
sive SQSTM1 gene. LAMP2A has a slow turnover, with a half-
life of approximately 46 h for total LAMP2A and 57 h for
lysosomal LAMP2A [33]. Hence, small changes in LAMP2A
mRNA levels may have a marked impact on protein levels and
CMA activity. Other studies show similar oscillations, further
supporting this notion [4,16,44,45]. In contrast with the dis-
crete changes in total cellular LAMP2A levels, the effects of
NFE2L2-deficiency are more dramatic in isolated lysosomes,
where LAMP2A is required for CMA. In fact, it has been
extensively shown before that levels of LAMP2A at the lyso-
somal membrane are the ones correlating with changes in the
rate of CMA [15]. As a result, CMA was barely detectable in
NFE2L2-deficient hepatocytes, suggesting a crucial role for
NFE2L2 in modulation of CMA.
While we have described the transcriptional regulation of
Lamp2a by NFE2L2, other layers of CMA regulation are still
possible. For example, lysosomes from nfe2l2-KO livers exhibited
higher levels of HSPA8 compared to Nfe2l2-WT livers. Although
it is possible that higher levels of HSPA8 are a result of the relative
decrease in lysosomal cargoes, we cannot discard the possibility
that the increase in lysosomal HSPA8 may represent a compen-
satory mechanism to counteract the decrease in LAMP2A levels.
In fact, increased HSPA8 levels have been previously reported in
other conditions with reduced lysosomal levels of LAMP2A, such
as livers from old mice and in lamp2a-KO mice [25,46].
The impairment of CMA in nfe2l2-KO mice was evidenced
by a deficient uptake in the in vitro reconstituted system of
RNASE but more importantly by the reduced degradation in
vivo of the endogenous bona fide CMA substrate GAPDH. The
fact that the differences in uptake in vivo of the endogenous
substrate are more pronounced than for the exogenously added
protein in the isolated in vitro system could be attributed to the
lack of other competing substrates in the latter. Interestingly, a
previous report showed that astrocyte-specific NFE2L2 overex-
pression reduced the levels of another CMA substrate, MEF2D
(myocyte enhancer factor 2D) [47]. However, this study was just
correlative and ours is the first one to show that changes in CMA
substrates are at the level of lysosomal degradation by CMA.
NFE2L2 has been reported to transcriptionally regulate
macroautophagy [22]. Crosstalk between both autophagic
pathways has been extensively reported both in vivo and in
vitro, whereby one reacts in a compensatory manner to the
loss of activity in the other [8,46,48]. However, in this work
we show that the functional connection between NFE2L2 and
CMA is independent of macroautophagy. Therefore, NFE2L2
might act as a regulatory node in the proteolytic network
represented by macroautophagy and CMA.
Both CMA [25,46] and NFE2L2 [49,50] activities decline
with age, probably favoring the accumulation of oxidized
substrates. A wide variety of NFE2L2 inducers have been
reported, and in fact, in this study we successfully used SFN
to increase Lamp2a mRNA and protein levels and increase
CMA activity. Considering the positive effect that genetic
restoration of CMA had in proteostasis of the livers of old
mice [44], it is reasonable to think that the pharmacological
reinforcement of NFE2L2 and consequently CMA would be
capable of a similar delay in the accumulation of oxidized
protein aggregates during aging.
Materials and methods
Cell culture and reagents
Adenocarcinoma human alveolar A549 cells and human
embryonic kidney HEK293T cells (ATCC, CCL-185 and
CRL-3216, respectively) were grown in Dulbecco’s modified
Eagle’s medium (Sigma-Aldrich, D5648) supplemented with
10% fetal bovine serum (HyClone, CH30160.03) and 80 μg/ml
gentamicin (Laboratorios Normon, 763,011.1). Immortalized
mouse hepatocytes were grown in the same medium supple-
mented with 10% fetal bovine serum, 2 mM glutamine
(Gibco/Life Technologies, 25,030–024), 1 mM sodium pyru-
vate (Gibco/Life Technologies, 11,360–039), 5 mM HEPES,
pH 7.4, 0.5 U/ml penicillin, 0.5 μg/ml streptomycin (Gibco/
Life Technologies, 15,140–122). Other reagents include:
Dihidroethiudium (Invitrogen, D11347). R,S-sulforaphane
(SFN; LKT Laboratories, Inc., S8044). Sucrose (Panreac,
131,621). Leupeptin hemisulfate salt (> 95%; L5793) and para-
quat (M2254) were purchased from Sigma-Aldrich. Transient
transfections were performed with GenJET™ In Vitro
Transfection Reagent from SignaGen (SL100488).
Bioinformatics analysis
Putative AREs in the LAMP2 gene were identified in
ENCODE [26] for the human genome taking as reference
the available information from ChIP of ARE binding factors
MAFK, MAFF and BACH1. The putative MAFK, MAFF and
BACH1 binding regions were localized in 200–400 base-pair-
long DNase-sensitive and H3K27Ac-rich regions. In addition,
a frequency matrix of the consensus ARE sequence based on
the JASPAR database [27] was converted to a position-specific
scoring matrix and a script was generated with the Python 3.4
program to scan the promoter sequences with candidate AREs
as previously described [22].
Chromatin immunoprecipitation (chip) assays
HEK293T cells were grown on 10-cm plates until they
reached 85% confluence and transfected with an NFE2L2
expression plasmid that lacks the high affinity binding site
for KEAP1 and contains a V5 tag (NFE2L2ΔETGE-V5) [51].
Briefly, cells were cross-linked with 1% formaldehyde (Fluka,
47,630) and the reaction was stopped with 125 mM glycine
(Bio-Rad, 161–0718). Cells were then washed twice with cold
phosphate-buffered saline (PBS; 10 mM PO4
3−, 137 mM
NaCl, 2.7 mM KCl, pH 7.4), lysed and sonicated in order to
obtain adequate fragment sizes of DNA. Supernatant was
diluted 10 fold with ChIP dilution buffer (0.01% sodium
dodecyl sulfate [Merck Millipore, 817,034], 1.1% Triton
X-100 [Sigma-Aldrich, T8787], 1.2 mM ethylenediaminete-
traacetic acid, 16.7 mM Tris-HCl, pH 8.1, 167 mM NaCl,
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1 mM phenylmethylsulfonyl fluoride [Sigma-Aldrich, P7626],
1 µg/ml leupeptin [Sigma-Aldrich, L5793]) and pre-cleared
with protein G Sepharose (GE Healthcare, 17–0618-01). ChIP
was carried out with anti-V5 antibody (Life Technologies,
37–7500) or anti-IgG (Abcam, ab18413). DNA was eluted
and purified, analyzing the presence of previously identified
putative AREs by quantitative real-time polymerase chain
reaction (qRT-PCR) with specific primers (Table S2).
Samples from at least 3 independent immunoprecipitations
were analyzed.
Luciferase reporter generation
Artificial oligonucleotides with 3 tandem repetitions of the
putative AREs identified separated with a BamHI sequence
and a random separating-sequence, as well as the scramble
sequence used as negative control, are described in Table S4.
These oligonucleotides were subcloned into NheI and XhoI
sites of the minimal Sod1 promoter pGL3basic-sod1-29 [52],
removing the NheI site to facilitate religated vector exclusion.
Scramble-LUC included also a SalI site instead of the separat-
ing-sequence to facilitate differentiation between the
constructs.
Luciferase activity
Transient transfections of nfe2l2-KO cells were performed
with the expression vectors ARE-LUC or SCRAMBLE-LUC
as indicated. pTK-Renilla was used as an internal control
vector. Luciferase assays were performed with the Dual-
Luciferase Reporter Assay System (Promega, E1910) as
described previously [53].
Production of lentiviral stocks and infection
Recombinant lentiviral stocks were produced in HEK293T/
17 cells by co-transfecting 10 μg of transfer vector (GFP or
NFE2L2ΔEGTE-V5), 6 μg of envelope plasmid pMD2.G
(Addgene, 12,259; deposited by Didier Trono) and 6 μg of
packaging plasmid pSPAX2 (Addgene, 12,260; deposited by
Didier Trono), using Lipofectamine® 2000 Reagent
(Invitrogen by Life Technologies, 116,668–019). After 12 h
at 37°C the medium was replaced with fresh Dulbecco’s
modified Eagle’s medium containing 10% fetal bovine
serum and virus particles were harvested at 24 h and 48 h
post-transfection. Cells were incubated in the presence of
2 µg/ml polybrene (Sigma-Aldrich, TR-1003-G) with the
lentivirus during 24 h and mRNA was extracted 3 days
after lentiviral transduction. Lentivirus carrying the
KFERQ-PS-Dendra reporter were prepared as described
previously [30] and added to hepatocytes in the presence
of 2 µg/ml polybrene 24 h before the beginning of the CMA
measurement.
Analysis of mrna levels
Total RNA extraction, reverse transcription and quantitative
PCR were carried out as detailed elsewhere [54]. Primer
sequences are shown in Tables S5 and S6. To ensure that
equal amounts of cDNA were added to the PCR, the house-
keeping genes Actb and Tbp were amplified. Data analysis was
based on the ΔΔCT method with normalization of the raw
data to housekeeping genes (Applied Biosystems, CA, USA).
All PCRs were performed at least in triplicate.
Immunoblotting
Immunoblots were performed as described elsewhere [55].
The primary antibodies used are presented in Table 2.
Membranes were analyzed using the appropriate peroxidase-
conjugated secondary antibodies (Life Technologies, A15999;
Amersham, NA931 and NA934; Merck Millipore, AP136P).
Proteins were detected by enhanced chemiluminescence (GE
Healthcare, RPN2232).
Animals and treatments
Animals were housed under a 12-h light-dark cycle. Food and
water were provided ad libitum and mice were cared for
according to protocols approved by the Ethics Committee
for Research of the Universidad Autónoma de Madrid follow-
ing institutional, Spanish and European guidelines (Boletín
Oficial del Estado of 18 March 1988; and 86/609/EEC, 2003/
65/EC European Council Directives). Where indicated, food
Table 2. Antibodies used in immunoblots, immunofluorescence and ChIP.
Antibody Source Catalog number Dilution
NFE2L2/NRF2 Cuadrado lab - 1:2000 (WB)
HMOX1 Enzo Life Sciences OSA110 1:2000 (WB)
SQSTM1/p62 Sigma Aldrich P0067 1:2000 (WB)
MmLAMP2A/Igp96 Zymed/Invitrogen 51–2200 1:1000 (WB). 1:100 (ICF)
HsLAMP2A Abcam ab18528 1:1000 (WB)
LAMP2B Cuervo lab - 1:1000 (WB)
LAMP2C Cuervo lab - 1:1000 (WB)
LAMP1 (1D4B) Hybridoma Bank 1D4B 1:1000 (WB). 1:250 (ICF)
RNASE Rockland Immunochemicals 100–188 1:5000 (WB)
HSPA8/HSC70 (13D3) Novus Biologicals NB1202788 1:5000 (WB)
ACTB Santa Cruz Biotechnology sc-1616 1:5000 (WB)
LMNB/lamin B Santa Cruz Biotechnology sc-6217 1:5000 (WB)
GAPDH Calbiochem CB1001 1:5000 (WB)
LC3B Cell Signaling Technology 2775 1:2000 (WB)
V5 Life Technologies 37–7500 1:250 (ChIP)
IgG2a Abcam ab18413 1:250 (ChIP)
ICF, immunocytofluorescence. WB, western blot. ChIP, chromatin immunoprecipitation.
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was removed for 24 h but water was still provided ad libitum.
Where stated, mice received intraperitoneal injections of vehi-
cle (0.9% saline buffer) or leupeptin (2 mg/100 g body weight)
16 h and 2 h before sacrifice.
Lysosomal isolation
For in vivo analysis, lysosomal-enriched fractions or CMA-
active lysosomes from Nfe2l2-WT and nfe2l2-KO mouse livers
were obtained as previously described [56]. Briefly, livers were
mechanically homogenized in 0.25 M sucrose, filtered through
double gauze and centrifuged at 6800 g. The supernatant was
then centrifuged at 17,000 g and the pellet was resuspended
with a ‘cold finger’ (dry glass test tube filled with ice). This
step was repeated twice to wash the lysosomal-enriched frac-
tion. Lysosomes active for CMA were isolated by centrifuga-
tion of the lysosomal-enriched fraction (light mitochondria
and lysosomes) in a discontinuous metrizamide (AK
Scientific, 69,696) density gradient [37,56]. The fraction of
broken lysosomes at the moment of isolation was measured
using the HEX/β-hexosaminidase latency assay [57]. In some
experiments, a crude lysosomal fraction was prepared from
hepatocytes derived from wild-type and nfe2l2-KO mice using
the Lysosome Isolation Kit from BioVision (K235-50) accord-
ing to the manufacturer’s instructions.
Immunocytofluorescence
Hepatocytes were seeded on sterile cover slips in 24-well
plates (75,000 cells per well), cultured for 16 h and treated
as indicated. Cells were washed with cold PBS and fixed in 4%
paraformaldehyde for 15 min at room temperature. After 3 5-
min washes with PBS, cells were incubated with blocking
solution (0.2% powdered milk, 2% normal goat serum
[Merck Millipore, NS20L], 0.1M glycine, 1% bovine serum
albumin [Sigma-Aldrich, A7906] and 0.01% Triton X-100) for
30 min at room temperature. After briefly washing twice with
PBS, the slides were incubated with the indicated primary
antibodies (Table 2) for 90 min at room temperature in a
humidified chamber. Then cells were washed 3 times with
PBS and incubated with secondary antibodies for 45 min
under the same conditions. To visualize the nuclei, cells
were stained with DAPI (4,6-diamidino-2-phenylindole).
The fluorescence images were captured using appropriate
filters in a Leica DMIRE2TCS SP5 confocal microscope
(Nussloch, Germany).
Measurement of CMA activity in intact cells
To measure CMA activity in intact cells the photoswitchable
KFERQ-PSDendra2 reporter was transduced into cells using
lentiviral delivery [30]. Cells were photoactivated with a 405-
nm light-emitting diode (LED: Norlux) for 4 min with the
intensity of 3.5 mA (current constant). After 16 h, cells were
fixed and slides prepared using mounting medium containing
DAPI (Abcam, ab104139) to highlight the cell nucleus. All
images were acquired with an Axiovert 200 fluorescence
microscope (Carl Zeiss Microscopy) with a 100x objective
and 1.4 numerical aperture, mounted with an ApoTome.2
slider. Quantification was performed in individual frames
after deconvolution and thresholding using ImageJ software
(NIH) in a minimum of 20 cells per slide. In all cases, focal
plane thickness was set at 0.17 μm and sections with maximal
nucleus diameter were selected for quantification. Values are
presented as number of puncta per cell section that in our
acquisition conditions represents 10–20% of the total puncta
per cell. CMA activation was detected as changes in the
fluorescence pattern from diffuse/cytosolic to punctate/lyso-
somal and quantified as the average number of fluorescent
puncta per cell or as the cellular area positive for KFERQ-
Dendra puncta [30]. Where indicated, high-content micro-
scopy was used instead to better determine dose-dependence
effects in a larger number of cells. Briefly, cells were plated in
glass-bottom 96-well plates, treated for the indicated times
and, after fixation, images were acquired using a high-content
microscope (Operetta, Perkin Elmer). Images of 9 different
fields per well were captured, resulting in an average of 2,500–
3,000 cells per condition. Nuclei and puncta were identified
using the manufacturer’s software. The number of particles/
puncta per cell was quantified using the ‘particle identifier’
function in the cytosolic region after thresholding in non-
saturated images [37].
Measurement of CMA in vitro
CMA activity in vitro was measured using isolated intact
lysosomes incubated with purified proteins and subjected to
immunoblot [37,56]. Binding was calculated as the amount of
substrate protein bound to the lysosomal membrane in the
absence of protease inhibitors, and uptake by subtracting the
amount of protein associated with lysosomes in the presence
(protein bound to the lysosomal membrane and taken up by
lysosomes) and absence (protein bound to the lysosomal
membrane) of protease inhibitors [37]. Proteolytic activity
was determined by incubating lysosomes with a cocktail of
long-lived radiolabeled proteins (3H-pool) previously demon-
strated to be enriched in CMA substrates [37,56] in the pre-
sence of 0.1% Triton X-100 to disrupt the lysosomal
membrane. Samples were incubated in 20 mM MOPS,
1 mM DTT, 5.4 µM cysteine (Sigma-Aldrich, 168,149), pH
7.3, 0.25 M sucrose (Sigma-Aldrich, S0389) for 20 min at
37ºC. At the end of the incubation, 10% TCA was added to
all the samples and they were subjected to filtration through a
0.2 μm filter, as previously described. Proteolysis was calcu-
lated as the percentage of acid precipitable radioactivity (pro-
tein) at the begging of the incubation that became acid soluble
(amino acids) at the end of the incubation [37].
Image analysis
Different band intensities corresponding to immunoblot
detection of protein samples were quantified using ImageJ
software. The number of puncta per cell was analyzed with
the ‘Analyze particles’ function of ImageJ after thresholding in
non-saturated images [30]. DHE fluorescence intensity was
quantified with ImageJ and is presented as the corrected total
cell fluorescence (CTCF; CTCF = integrated density – [area of
selected cell x mean fluorescence of background readings]).
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Perinuclear LAMP2A fluorescence was measured with the
‘Radial profile angle’ plugin of ImageJ after properly calibrat-
ing the image. A circular mask with a radius of 100 pixels
(25 µm, approximately) was used to analyze fluorescence
intensity per cell. For each cell, the algorithm measured the
mean signal intensity in a series of concentric circles drawn
along the established radius, starting from the nucleus and
towards the cell periphery. Quantifications were performed in
50–75 cells per condition in 3 independent experiments.
Statistical analysis
Unless otherwise indicated, all experiments were performed at
least 3 times and all data presented in the graphs are the mean
of at least 3 independent samples ± standard error (SD).
Student’s t-test was used to assess differences between groups.
p < 0.05 was considered significant.
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